Machine Learning

Mackenzie Investments' 2026 forecast warns of fewer Fed cuts than expected, highlighting opportunities in AI-driven equities and strategic commodities.

Kyndryl names internal successor Mark Paulek as CHRO, signaling a strategic focus on talent continuity and AI-readiness for its global workforce.

A new AI-powered index assigns ships a 0-5 transparency score, aiming to expose sanctions evaders and reshape maritime insurance and global trade.

A validated dry EEG headset provides a scalable, objective measure of brain plasticity, promising to accelerate drug discovery for Alzheimer's and depression.

Early trial data for IKS014 reveals a high clinical benefit rate in pre-treated oesophageal cancer, offering a new beacon of hope for a hard-to-treat disease.

Iron Software funds biochar kilns in Chiang Mai, tackling an environmental crisis that threatens the city's 'mini Silicon Valley' status.

San Diego's Ikotek USA moves manufacturing to Mexico, leveraging TAA compliance and USMCA to build a resilient supply chain for the US market.

The fresh food packaging market is set to soar, but can it balance consumer demands for sustainability, safety, and convenience with the high costs of innovation?

At CES 2026, Silicon Labs launched its Simplicity SDK for Zephyr, bridging open-source flexibility with commercial support for next-gen IoT.

IP Atlas Media launches IPAC, a new model for valuing intellectual property, aiming to redefine economic strength in a world driven by intangible assets.

Opus Fund Services launches SmartWire, an AI-driven platform designed to automate payments and secure fund managers against fraud and operational risks.

Future FinTech and quant firm S1Quant partner to build a compliant bridge for institutional investors into the volatile world of cryptocurrency assets.

Following a period of mixed financials, Neogen appoints new leaders to drive innovation and growth in its critical global food safety division.

As it marks 32 years, Alexandria Real Estate Equities proves its resilience, dominating the market it created amid industry-wide headwinds.

BridGene Biosciences adds Nobel winner Dr. Bruce Beutler to its board, gaining immense credibility for its mission to create drugs for intractable diseases.

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

With a $257M war chest and a veteran team, BlossomHill will showcase its innovative pipeline for lung cancer and leukemia at the pivotal JPM conference.

William Healey, a 25-year veteran, takes the helm as IAAO's 2026 President, guiding the future of global property valuation amid technological change.

With surging revenue for its cholesterol drugs and new guideline backing, Esperion outlines its strategy for profitability and pipeline expansion.

With 35 years at the company, new CEO John Baylouny plans to accelerate R&D and expand into new markets, building on a period of strong growth.